← back to search

Xiaodan Wu

Fujian Medical University · CN
Area of research
Materials Chemistry · Biomedical Engineering
Research interest
Research interests include Nanoplatforms for cancer theranostics, Microbial Natural Products and Biosynthesis, Carbon and Quantum Dots Applications, and Advanced Nanomaterials in Catalysis.
h-index
38
citations
4,889
works
303
NIH funding
primary concept
email

Recent publications

microRNA-196b-5p expression in cancer tissues is closely associated with clinical and pathological characteristics and prognosis of patients with non-small cell lung cancer
Journal of Cardiothoracic Surgery 2025cited by 2position: lastdoi
Transcriptomic reveals the effect of tannic acid stress on the cellular structure and growth of Saccharomyces cerevisiae
Food Bioscience 2024cited by 5position: middledoi
Identification of Species-Specific Prey Uptake and Biotransformation of Chiral Polychlorinated Biphenyls (PCBs) in Riparian and Aquatic Food Webs
Environmental Science & Technology 2023cited by 4position: middledoi
Comparative Metabolomics Reveals Fungal Conversion of Co-Existing Bacterial Metabolites within a Synthetic Aspergillus-Streptomyces Community
Marine Drugs 2021cited by 16position: middledoi
Competing endogenous RNA network for esophageal cancer progression
Annals of Translational Medicine 2021cited by 9position: middledoi
Heterozygous SOD2 deletion deteriorated chronic intermittent hypoxia-induced lung inflammation and vascular remodeling through mtROS-NLRP3 signaling pathway
Acta Pharmacologica Sinica 2020cited by 48position: middledoi
Polycyclic meroterpenoids, talaromyolides E − K for antiviral activity against pseudorabies virus from the endophytic fungus Talaromyces purpureogenus
Tetrahedron 2020cited by 28position: middledoi
Talaromyolides A–D and Talaromytin: Polycyclic Meroterpenoids from the Fungus <i>Talaromyces</i> sp. CX11
Organic Letters 2019cited by 57position: middledoi
Universal screening for Lynch syndrome in a large consecutive cohort of Chinese colorectal cancer patients: High prevalence and unique molecular features
International Journal of Cancer 2018cited by 54position: middledoi
Stress-Driven Discovery of New Angucycline-Type Antibiotics from a Marine Streptomyces pratensis NA-ZhouS1
Marine Drugs 2018cited by 48position: middledoi
Gastric cancer-derived MSC-secreted PDGF-DD promotes gastric cancer progression
Journal of Cancer Research and Clinical Oncology 2014cited by 54position: middledoi
Two Novel Hepatocellular Carcinoma Cycle Inhibitory Cyclodepsipeptides from a Hydrothermal Vent Crab-Associated Fungus Aspergillus clavatus C2WU
Marine Drugs 2013cited by 57position: middledoi
Can lung cancer stem cells be targeted for therapies?
Cancer Treatment Reviews 2012cited by 66position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Bin Wu · University of Massachusetts Amherst5 papers (2013–2021)Yutong Shi · Ningbo University4 papers (2018–2021) · 4 papers (2013–2020)Shan He · Ningbo University3 papers (2013–2021)Wei Jiang · Ningbo University2 papers (2013–2021)Hongxiang Sun · Shandong University2 papers (2019–2020)Jeroen S. Dickschat · Technical University of Munich2 papers (2019–2020)Xun Cao · Oak Ridge National Laboratory2 papers (2019–2020)Li‐She Gan · Guangzhou University of Chinese Medicine1 papers (2013–2013)Pengyuan Liu · University of Massachusetts Lowell1 papers (2013–2013)Ying Ye · Wenzhou Medical University1 papers (2013–2013)Mei Wang · Jiangsu University1 papers (2014–2014)Qiang Zhang · Northwestern University1 papers (2014–2014)Na Liu · Weifang Medical University1 papers (2024–2024)Xiangdong Wang · Tufts University1 papers (2012–2012)Wei Liu · Weifang Medical University1 papers (2025–2025)Qing Wang · Tulane University1 papers (2021–2021)Xu Zhang · Affiliated Zhongshan Hospital of Dalian University1 papers (2014–2014)Zilong Liu · Guiyang Medical University1 papers (2020–2020)Yanru Chen · Nanchang University1 papers (2024–2024)